Multifunctional cationic host defence peptides and their clinical applications
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bals R, Weiner DJ, Moscioni AD, Meegalla RL, Wilson JM (1999) Augmentation of innate host defence by expression of a cathelicidin antimicrobial peptide. Infect Immun 67:6084–6089
Barlow PG, Li Y, Wilkinson TS, Bowdish DM, Lau YE, Cosseau C, Haslett C, Simpson AJ, Hancock RE, Davidson DJ (2006) The human cationic host defence peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol 80:509–520
Bastian A, Schafer H (2001) Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul Pept 101:157–161
Befus AD, Mowat C, Gilchrist M, Hu J, Solomon S, Bateman A (1999) Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol 163:947–953
Biragyn A, Belyakov IM, Chow YH, Dimitrov DS, Berzofsky JA, Kwak LW (2002) DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses. Blood 100:1153–1159
Boman HG, Agerberth B, Boman A (1993) Mechanisms of action on Escherichia coli of cecropin-P1 and PR-39, 2 antibacterial peptides from pig intestine. Infect Immun 61:2978–2984
Bommarius B, Jenssen H, Elliott M, Kindrachuk J, Pasupuleti M, Gieren H, Jaeger KE, Hancock REW, Kalman D (2010) Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 31:1957–1965
Bowdish DME, Davidson DJ, Hancock REW (2005) A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci 6:35–51
Bowdish DME, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock REW (2005) Impact of LL-37 on anti-infective immunity. J Leukoc Biol 77:451–459
Braff MH, Zaiou M, Fierer J, Nizet V, Gallo RL (2005) Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect Immun 73:6771–6781
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238–250
Brown KL, Hancock REW (2006) Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 18:24–30
Cherkasov A, Hilpert K, Jenssen H, Fjell CD, Waldbrook M, Mullaly SC, Volkmer R, Hancock REW (2009) Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol 4:65–74
Cunliffe RN, Mahida YR (2004) Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J Leukoc Biol 75:49–58
Davidson DJ, Currie AJ, Reid GSD, Bowdish DME, MacDonald KL, Ma RC, Hancock REW, Speert DP (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 172:1146–1156
de Lucca AJ, Walsh TJ (1999) Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrobial Agents Chemother 43:1–11
Doi K, Hu X, Yuen PST, Leelahavanichkul A, Yasuda H, Kim SM, Schnermann J, Jonassen TEN, Frokiaer J, Nielsen S, Star RA (2008) AP214, an analogue of α-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney Int 73:1266–1274
Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gudmundsson GH, Gallo RL (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117:91–97
Easton DM, Nijnik A, Mayer ML, Hancock REW (2009) Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol 27:582–590
Ehrenstein G, Lecar H (1977) Electrically gated ionic channels in lipid bilayers. Q Rev Biophys 10:1–34
Falla TJ, Zhang L (2010) Efficacy of hexapeptide-7 on menopausal skin. J Drugs Dermatol 9:49–54
Finlay BB, Hancock REW (2004) Can innate immunity be enhanced to treat microbial infections? Nat Rev Microbiol 2:497–504
Friedrich CL, Moyles D, Beveridge TJ, Hancock REW (2000) Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria. Antimicrob Agents Chemother 44:2086–2092
Friedrich CL, Rozek A, Patrzykat A, Hancock REW (2001) Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J Biol Chem 276:24015–24022
Fukumoto K, Nagaoka I, Yamataka A, Kobayashi H, Yanai T, Kato Y, Miyano T (2005) Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats. Pediatr Surg Int 21:20–24
Ganz T, Metcalf JA, Gallin JI, Boxer LA, Lehrer RI (1988) Microbicidal cytotoxic proteins of neutrophils are deficient in 2 disorders—Chediak–Higashi syndrome and specific granule deficiency. J Clin Invest 82:552–556
Gartner MH, Benson JD, Caldwell MD (1992) Insulin-like growth factor I and factor II expression in the healing wound. J Surg Res 52:389–394
Glaser V (2009) Competition mounting in peptide market. GEN 29:38–41
Grieco P, Rossi C, Colombo G, Gatti S, Novellino E, Lipton JM, Catania A (2003) Novel alpha-melanocyte stimulating hormone peptide analogues with high candidacidal activity. J Med Chem 46:850–855
Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Terán LM (2010) Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 135:1–11
Haines LR, Thomas JM, Jackson AM, Eyford BA, Razavi M, Watson CN, Gowen B, Hancock REW, Pearson TW (2009) Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18. PLoS Negl Trop Dis 3:e373
Hale JDF, Hancock REW (2007) Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther 5:951–959
Hallock KJ, Lee DK, Ramamoorthy A (2003) MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophys J 84:3052–3060
Hancock REW, Sahl H (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551–1557
Hancock REW, Brown KL, Mookherjee N (2006) Host defence peptides from invertebrates—emerging antimicrobial strategies. Immunobiology 211:315–322
Hancock REW, Diamond G (2000) The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8:402–410
Hancock REW, Lehrer R (1998) Cationic peptides: a new source of antibiotics. Trends Biotechnol 16:82–88
Hancock REW, Scott MG (2000) The role of antimicrobial peptides in animal defences. Proc Natl Acad Sci U S A 97:8856–8861
Hancock RE (2001) Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1:156–164
Hirsch T, Spielmann M, Zuhaili B, Fossum M, Metzig M, Koehler T, Steinau H, Yao F, Onderdonk AB, Steinstraesser L, Eriksson E (2009) Human beta-defensin-3 promotes wound heating in infected diabetic wounds. J Gene Med 11:220–228
Horne WS, Wiethoff CM, Cui CL, Wilcoxen KM, Amorin M, Ghadiri MR, Nemerow GR (2005) Antiviral cyclic d,l-alpha-peptides: targeting a general biochemical pathway in virus infections. Bioorg Med Chem 13:5145–5153
Hsu ST, Breukink E, Tischenko E, Lutters MA, de Kruijff B, Kaptein R, Bonvin AM, van Nuland NA (2004) The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat Struct Mol Biol 11:963–967
Jenssen H, Hancock RE (2010) Therapeutic potential of HDPs as immunomodulatory agents. Methods Mol Biol 618:329–347
Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B (1998) Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273:3718–3724
Juliano RL, Alam R, Dixit V, Kang HM (2009) Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:324–335
Kindrachuk J, Jenssen H, Elliott M, Townsend R, Nijnik A, Lee SF, Gerdts V, Babiuk LA, Halperin SA, Hancock REW (2009) A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. Vaccine 27:4662–4671
Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbruicker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111:1665–1672
Koo JC, Lee B, Young ME, Koo SC, Cooper JA, Baek D, Lim CO, Lee SY, Yun DJ, Cho MJ (2004) Pn-AMP1, a plant defence protein, induces actin depolarization in yeasts. Plant Cell Physiol 45:1669–1680
Kovacs-Nolan J, Mapletoft JW, Latimer L, Babiuk LA, den Hurk S (2009) CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle. Vaccine 27:2048–2054
Lee DG, Kim PI, Park YK, Woo ER, Choi JS, Choi CH, Hahm KS (2002) Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid. Biochem Biophys Res Commun 293:231–238
Lee HS, Park CB, Kim JM, Jang SA, Park IY, Kim MS, Cho JH, Kim SC (2008) Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. Cancer Lett 271:47–55
Lehrer RI, Barton A, Daher KA, Harwig SSL, Ganz T, Selsted ME (1989) Interaction of human defensins with Escherichia coli—mechanism of bactericidal activity. J Clin Invest 84:553–561
Lehrer RI, Szklarek D, Ganz T, Selsted ME (1985) Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect Immun 49:207–211
Li JF, Zhang J, Song R, Zhang JX, Shen Y, Zhang SQ (2009) Production of a cytotoxic cationic antibacterial peptide in Escherichia coli using SUMO fusion partner. Appl Microbiol Biotechnol 84:383–388
Lillard JW, Boyaka PN, Chertov O, Oppenheim JJ, McGhee JR (1999) Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc Natl Acad Sci U S A 96:651–656
Lipsky B, Holroyd K, Zasloff M (2008) Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 47:1537–1545
Lisy O, Huntley BK, McCormick DJ, Kurlansky PA, Burnett JC Jr (2008) Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. J Am Coll Cardiol 52:60–68
Lorin C, Saidi H, Belaid A, Zairi A, Baleux F, Hocini H, Belec L, Hani K, Tangy F (2005) The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology 334:264–275
Lustig F, Hoebeke J, Ostergren-Lunden G, Velge-Roussel F, Bondjers G, Olsson U, Ruetschi U, Fager G (1996) Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans. Biochemistry (NY) 35:12077–12085
Mader JS, Hoskin DW (2006) Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 15:933–946
Marr AK, Gooderham WJ, Hancock REW (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6:468–472
Matsuzaki K, Murase O, Fujii N, Miyajima K (1996) An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry (NY) 35:11361–11368
Mayer ML, Easton DM, Hancock REW (2010) Fine tuning host responses in the face of infection: emerging roles and clinical applications of host defense peptides. In: Wamg G (ed) Antimicrobial peptides: discovery, design and novel therapeutic strategies. CABI, Wallingford, UK
McCann KB, Lee A, Wan J, Roginski H, Coventry MJ (2003) The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. J Appl Microbiol 95:1026–1033
Migenix (2009) Migenix announces Omigard phase III clinical trial results. Available via http://www.migenix.com/prod_summaries.php. Accessed 19 Mar 2009
Mookherjee N, Hancock REW (2007) Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 64:922–933
Mookherjee N, Lippert DND, Hamill P, Falsafi R, Nijnik A, Kindrachuk J, Pistolic J, Gardy J, Miri P, Naseer M, Foster LJ, Hancock REW (2009) Intracellular receptor for human host defense peptide LL-37 in monocytes. J Immunol 183:2688–2696
Murakami T, Nakajima T, Koyanagi N, Tachibana K, Fujii N, Tamamura H, Yoshida N, Waki M, Matsumoto A, Yoshie O, Kishimoto T, Yamamoto N, Nagasawa T (1997) A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med 186:1389–1393
Mutwiri G, Gerdts V, Lopez M, Babiuk LA (2007) Innate immunity and new adjuvants. Rev Sci Tech 26:147–156
Nijnik A, Hancock RE (2009) The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol 16:41–47
Nijnik A, Madera L, Ma S, Waldbrook M, Elliott MR, Easton DM, Mayer ML, Mullaly SC, Kindrachuk J, Jenssen H, Hancock REW (2010) Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J Immunol 184:2539–2550
Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H, Nagaoka I (2002) A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106:20–26
Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I (2001) Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D2 production from mast cells. Eur J Immunol 31:1066–1075
Nizet V (2006) Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol 8:11–26
Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454–457
Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DYM (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151–1160
Papo N, Braunstein A, Eshhar Z, Shai Y (2004) Suppression of human prostate tumor growth in mice by a cytolytic d-,l-amino acid peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res 64:5779–5786
Papo N, Seger D, Makovitzki A, Kalchenko V, Eshhar Z, Degani H, Shai Y (2006) Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defence-like lytic peptide. Cancer Res 66:5371–5378
Papo N, Shai Y (2004) Effect of drastic sequence alteration and d-amino acid incorporation on the membrane binding behavior of lytic peptides. Biochemistry (NY) 43:6393–6403
Park CB, Kim HS, Kim SC (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244:253–257
Park Y, Jang SH, Lee DG, Hahm KS (2004) Anti-nematodal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Caenorhabditis elegans. J Pept Sci 10:304–311
Patrzykat A, Friedrich CL, Zhang LJ, Mendoza V, Hancock REW (2002) Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother 46:605–614
Pietrantoni A, Ammendolia MG, Tinari A, Siciliano R, Valenti P, Superti F (2006) Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection. Antiviral Res 69:98–106
Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y (1992) Interaction of antimicrobial dermaseptin and its fluorescently labelled analogs with phospholipid-membranes. Biochemistry (NY) 31:12416–12423
Putsep K, Carlsson G, Boman HG, Andersson M (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360:1144–1149
Rappolee DA, Mark D, Banda MJ, Werb Z (1988) Wound macrophages express TGF-alpha and other growth-factors in vivo—analysis by messenger-RNA phenotyping. Science 241:708–712
Rose RA (2010) CD-NP, a chimeric natriuretic peptide for the treatment of heart failure. Curr Opin Investig Drugs 11:349–356
Sahl HG, Pag U, Bonness S, Wagner S, Antcheva N, Tossi A (2005) Mammalian defensins: structures and mechanism of antibiotic activity. J Leukoc Biol 77:466–475
Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522–526
Sandgren S, Wittrup A, Cheng F, Jönsson M, Eklund E, Busch S, Belting M (2004) The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J Biol Chem 279:17951–17956
Sawant R, Torchilin V (2010) Intracellular transduction using cell-penetrating peptides. Mol Biosyst 6:628–640
Schweizer F (2009) Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol 625:190–194
Scott MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock REW (2007) An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol 25:465–472
Shai Y, Oren Z (2001) From “carpet” mechanism to de novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 22:1629–1641
Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu LD, Ganz T, Borregaard N (2003) Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170:5583–5589
Steinberg D, Hurst M, Fujii C, Kung A, Ho J, Cheng F, Loury D, Fiddes J (1997) Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 41:1738–1742
Steinstraesser L, Kraneburg UM, Hirsch T, Kesting M, Steinau H, Jacobsen F, Al-Benna S (2009) Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int J Mol Sci 10:3951–3970
Steinstraesser L, Koehler T, Jacobsen F, Daigeler A, Goertz O, Langer S, Kesting M, Steinau H, Eriksson E, Hirsch T (2008) Host defense peptides in wound healing. Mol Med 14:528–537
Subbalakshmi C, Sitaram N (1998) Mechanism of antimicrobial action of indolicidin. FEMS Microbiol Lett 160:91–96
Svenson J, Stensen W, Brandsdal B, Haug BE, Monrad J, Svendsen JS (2008) Antimicrobial peptides with stability toward tryptic degradation. Biochemistry (NY) 47:3777–3788
Tamamura H, Xu YO, Hattori T, Zhang XY, Arakaki R, Kanbara K, Omagari A, Otaka A, Ibuka T, Yamamoto N, Nakashima H, Fujii N (1998) A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. Biochem Biophys Res Commun 253:877–882
Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I, Funakoshi S, Asai O, Herrmann SH, Wang JM, Kwak LW, Oppenheim JJ (2000) Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol 12:691–700
Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, Rabe KF, Hiemstra PS (2003) The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 171:6690–6696
Travis S, Yap LM, Hawkey C, Warren B, Lazarov M, Fong T, Tesi RJ, Group RIS (2005) RDP58 is a novel and potentially effective oral therapy for ulcerative colitis. Inflamm Bowel Dis 11:713–719
Trotti A, Garden A, Warde P, Symonds P, Langer C, Redman R, Pajak TF, Fleming TR, Henke M, Bourhis J, Rosenthal DI, Junor E, Cmelak A, Sheehan F, Pulliam J, Devitt-Risse P, Fuchs H, Chambers M, O’Sullivan B, Ang KK (2004) A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys 58:674–681
Uzzell T, Stolzenberg ED, Shinnar AE, Zasloff M (2003) Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides 24:1655–1667
van der Does AM, Bogaards SJP, Ravensbergen B, Beekhuizen H, van Dissel JT, Nibbering PH (2010) Antimicrobial peptide hLF1–11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens. Antimicrobial Agents Chemother 54:811–816
Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, Fellermann K, Schroeder JM, Stange EF (2003) Inducible and constitutive beta-defensins are differentially expressed in Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis 9:215–223
Wildman KAH, Lee DK, Ramamoorthy A (2003) Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry (NY) 42:6545–6558
Wu MH, Maier E, Benz R, Hancock REW (1999) Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry (NY) 38:7235–7242
Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ (2004) Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 22:181–215
Yang D, Biragyn A, Kwak LW, Oppenheim JJ (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23:291–296
Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192:1069–1074
Yang L, Harroun TA, Weiss TM, Ding L, Huang HW (2001) Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J 81:1475–1485
Zasloff M (2006) Inducing endogenous antimicrobial peptides to battle infections. Proc Natl Acad Sci U S A 103:8913–8914
Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin—isolation, characterization of 2 active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84:5449–5453
Zhang LJ, Rozek A, Hancock REW (2001) Interaction of cationic antimicrobial peptides with model membranes. J Biol Chem. 276:35714–35722
Zhang L, Parente J, Harris SM, Woods DE, Hancock REW, Falla TJ (2005) Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother 49:2921–2927